Projekt

Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in elderly patients with KRAS- and BRAF wild-type metastatic colorectal cancer. A multicenter phase II trial, Leit-EK Zürich

Abgebrochen · 2013 bis 2022

Horber Daniel, Gueller Ulrich, Diem Stefan